This news matters as it highlights the progress of United Health Products in meeting FDA requirements for its hemostatic gauze product. The successful completion of sterilization and biotoxicity tests is a significant step towards accessing the human surgical market. Investors and stakeholders will be monitoring the outcome of the FDA Premarket Approval and OTCQB uplisting applications."
https://newsramp.com/curated-news/united-heal...a3f936d8aa
Do your d/d!
$5-$10.